Jasper Therapeutics, Inc.
USD0.53
-0.02 (-3.45%)
CEO
Jeetinder Singh Mahal
IPO Date
2020-01-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.55
Prev. Close
$0.55
Day Low
$0.49
Day High
$0.64
52W Low
$0.43
52W High
$7.19
Market Cap
$0.01B
Volume
1.64M
| 234,000 |
| $1.84 |
| 5 Jan 2026 | Mahal Jeetinder Singh | Chief Operating Officer | A-Award | Acquired | 90,000 | $1.84 |
| 5 Jan 2026 | CROSS HERB | Chief Financial Officer | A-Award | Acquired | 90,000 | $1.84 |
| 24 Sept 2025 | WIGGANS THOMAS G | director | P-Purchase | Acquired | 41,000 | $2.43 |
| 24 Sept 2025 | WIGGANS THOMAS G | director | P-Purchase | Acquired | 41,000 | $2.92 |
| 24 Sept 2025 | Lucas Svetlana | director | P-Purchase | Acquired | 20,000 | $2.43 |
| 24 Sept 2025 | Lucas Svetlana | director | P-Purchase | Acquired | 20,000 | $2.92 |
| 24 Sept 2025 | MARTELL RON | director, officer: President and CEO | P-Purchase | Acquired | 41,000 | $2.43 |
| 24 Sept 2025 | MARTELL RON | director, officer: President and CEO | P-Purchase | Acquired | 41,000 | $2.92 |